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Abstract 
Intense Pulsed Light (IPL) photodepilation is usually performed as a hair removal method. The treatment is recom-
mended to be indicated by a physician, depending on each patient and on its characteristics. However, the use of la-
ser devices by medical laypersons is frequent and it can suppose a risk of damage for the patients. Most side effects 
associated to IPL photodepilation are transient, minimal and disappear without sequelae. However, permanent side 
effects can occur. Some of the complications are laser related but many of them are caused by an operator error or 
mismanagement. In this work, we report a clinical case of a patient that developed a chronic neuropathic facial pain 
following IPL hair removal for unwanted hair in the upper lip. The specific diagnosis was painful post-traumatic 
trigeminal neuropathy, reference 13.1.2.3 according to the International Headache Society (IHS). 
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Introduction
Nowadays laser and light sources are used worldwide 
for different treatments especially for permanent or pro-
longed hair removal. Their easy and fast application, 
non-invasiveness, and few minimal and transient known 
side effects have made them very popular (1).
Although Intense Pulsed Light (IPL) photodepilation 
is an effective and safe hair removal method, caution 
should be considered by practitioners and patients to 
avoid permanent side effects (2,3).
Chronic facial pain after a hair removal treatment with 
IPL has not been reported. The authors present a case of 
chronic neuropathic facial pain after IPL hair removal.
Case Report
A 58-year-old Caucasian female was seen at the Oro-
facial Pain Unit of the Oral and Maxillofacial Master 
Degree Program at the University of Barcelona with a 5 
year history of orofacial pain following IPL hair removal 
for unwanted hair in the upper lip. Two different wave 
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lengths and IPL sources were used during the procedure 
(650 nm cut-filter, Lovely, Alma, Israel and 695 nm cut-
filter, Quantum, Israel). The patient referred that from the 
fourth IPL treatment session, she started suffering severe 
(8/10 on a Visual Analog Scale (VAS)), constant pain 
and numbness localized at the anterior hard palate, the 
upper central incisors, the buccal side mucosa and sub-
nasal area. She reported that non-opioid analgesics such 
as ibuprofen were unsuccessful in controlling the pain. 
During the initial visit at our unit, the patient signed an 
informed consent to be attended there, underwent a tho-
rough anamnesis and clinical examination that included 
panoramic X-rays (Figs. 1,2) and periapical radiographs 
Fig. 1. Clinical examination: intraoral frontal view.
Fig. 2. Panoramic dental radiology.
of the painful area. These examinations did not show 
any relevant abnormalities. Her personal medical history 
revealed no toxic habits, acetylsalicylic acid intoleran-
ce, chronic rhinitis (2004), hysterectomy (2005), kid-
ney lithiasis (2008), osteoarthritis and primary essential 
hypertension (controlled with diet). Current medication 
included calcium 60 mg QD and paracetamol (acetami-
nophen) 1 gr on demand. The whole patient interview 
was performed by a dentist with advanced training in 
the management of Orofacial Pain conditions following 
the guidelines of the American Academy of Orofacial 
Pain and the International Headache Society (IHS) (4). 
Although the symptoms were bilateral, all other charac-
teristics agreed with diagnostic criteria of a V2 painful 
post-traumatic trigeminal neuropathy (IHS 13.1.2.3). 
Nasopalatine nerve provides innervation to palatal gin-
giva and mucosa, and the nasal septum. This is a unique 
case because nasopalatine nerve is located at the midline 
and the affected structures are bilateral. Initial treatment 
began with educating the patient to the condition and 
teaching her some basic physical self-regulating strate-
gies to reduce sympathetic nervous system up-regula-
tion (diaphragmatic breathing). A series of blood tests 
(complete blood count, kidney and liver function, full 
ionogram, lipid panel and fasting glucose levels) were 
requested in order to obtain baseline parameters before 
the administration of any medication. All results were 
normal. 
Medical management began with amitriptyline 25 mg 
QHS with a discrete improvement of pain intensity after 
4 weeks of treatment. This medication was then associa-
ted with clonazepam (Rivotryl, Roche Farma, Madrid, 
Spain) 0.25 mg BID. Two months later, the patient re-
ferred substantial improvement (1-2/10 VAS) of pain in 
the nasal area and upper anterior teeth, complaining only 
of a mild discomfort in the anterior hard palate. Clona-
zepam was adjusted to 0.25 mg TID. Three months later 
the patient reported gastric distress and therefore ami-
triptyline was changed for duloxetine 30 mg QD and 
omeprazole 20 mg QD was added to the pharmacologic 
protocol. This change in the medication did not provoke 
any substantial alteration in pain control; however, gas-
tric distress was controlled satisfactory. This medication 
protocol has been maintained over a two year follow-up 
period in which the patient has remained virtually as-
ymptomatic, reporting no major side effects from the 
medication use. 
Discussion
Definitive diagnosis of chronic orofacial pain is cha-
llenging. However, this situation is relatively frequent 
for dentists because persistent and chronic pain is more 
common in the head and neck region than in any other 
part of the body. Following identical injuries, the onset 
of neuropathic pain and its characteristics varies indivi-
dually. Such variability is probably due to a combina-
tion of environmental psychosocial and genetic factors. 
Some patients develop chronic pain following a negligi-
ble nerve trauma such as root canal therapy. Besides, it 
is widely known that third molar extractions may lead 
to disturbed sensation in the lingual or inferior alveo-
lar nerve for varying periods. Some other procedures as 
dental implant placement or orthognathic jaw surgery 
may produce permanent sensory dysfunction. Neverthe-
less, the incidence of chronic pain is still unclear (5).
It is unlikely that our patient already had an undiagnosed 
chronic facial pain and that it was overlooked before IPL 
hair removal treatment since dental therapy (endodon-
tic treatment) in the painful area was performed several 
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years before IPL use, with no discomfort and/or pain re-
ported then by the patient. Although IPL photodepilation 
is an effective and safe hair removal method, caution 
should be considered to avoid permanent side effects 
(2,3). IPL photodepilation procedure is painful. The ma-
jority of patients experience mild pain during treatment 
administration but it should always be tolerable especia-
lly if sensitive areas such as the upper lip are being depi-
lated. Administration of local anaesthesia is not usually 
recommended for adult patients because pain is the best 
early warning system to prevent side effects caused by 
heat destruction. If the patient complains about intolera-
ble pain, the risk of adverse effects is high (3,6).
Despite the specificity of light sources used today, com-
plications may still appear. Although some of the com-
plications are laser related, many are still caused by an 
operator error, either in consciousness or by a postope-
rative mismanagement (3). The use of light and laser de-
vices by medical laypersons poses a real threat to public 
health and the potential damage should not be under-
estimated (7). Fortunately, most side effects associated 
to IPL photodepilation are transient, minimal and they 
disappear without sequelae. Foliculitis, pigmentary alte-
rations relating to skin color, blisters and crusts, erythe-
ma and edema are the most common adverse effects (6). 
Concretely, Fodor et al. (2) mentioned that hypopigmen-
tation is less frequently reported in the literature compa-
red with hyperpigmentation. Likewise, Hammes et al. 
(7) performed a retrospective study to evaluate treatment 
errors arising from laser and IPL treatments by layper-
sons. A standardized survey and a photo-documentation 
were given to the participants. From a total of 50 pa-
tients, the reported complications were pigmentation 
changes (81.4 %), scarring (25.6 %), textural changes 
(14 %) and inadequate information without physical 
injury (4.6%). Another known side effect is called “pa-
radoxical” effect (more hair in close proximity to the 
treated area) (1,2,6,7). The mechanism for paradoxical 
hypertrichosis is not known. Moreno-Arias et al. (6) 
believes that sublethal doses of IPL may have induced 
activation of dormant follicles.
Even though permanent side effects exceptionally occur, 
they are possible and seem to be related to use of high 
fluences (superficial burning, isolated vesicles), infection 
(scar formation), and dark skin (pigmentary alterations, 
especially in phototypes higher than IV) (6). This is in 
accordance with the results found in the study performed 
by Hammes et al. (7) that reported treatment errors done 
in 50 patients that consisted in excessive energy appli-
cation (62.8 % of patients), wrong device used for the 
indication (39.5 %), a deep tan or a skin tone too dark 
for the intervention (20.9 %), inadequate cooling (7%) 
and inadequate information (4.6%). Only a few perma-
nent side effects have been reported in the literature. 
Fodor et al. (2) reported one case of hypopigmentation 
and one case of leukotrichia. Moreover, Moreno-Arias 
et al. (6) obtained a minimal atrophic scar in the sub-
mandibular area. They also mentioned that one patient 
experienced persistent local heat sensation (not burning) 
without erythema or other symptoms. Sperber et al. (8) 
reported a 21-year-old woman who experienced a seve-
re blistering eruption meanwhile Shin et al. (9) exposed 
a case of a 41-year-old woman who developed vitiligo 
on the cheek and the mandibular area following an IPL 
treatment. 
Proper patient selection is mandatory for reasonable 
success rates. It is up to the practitioner to determine 
whether each individual patient is suitable for laser 
treatment and whether the correct technology and skills 
are available for treatment (3). Physicians should always 
make the indication for the treatment and are responsible 
for setting the machine for each individual patient and 
treatment. The type of laser or IPL and their specific pa-
rameters must be adapted to the indication (such as the 
vessels characteristics or the Fitzpatrick skin type). 
Treatments should start on a test patch and a treatment 
grid could improve accuracy. It is important to carefully 
observe the treated test spot for at least 5 minutes before 
proceeding with the full treatment and before each ses-
sion. The treatment parameters should be adjusted ac-
cording to the skin response from the previous session. 
Cooling has become an integral part of laser treatments 
(cryogen spray, cold sapphire contact handpieces or air 
pre-cooled and blown across the skin surface). These 
devices promote rapid epidermal cooling to lower tem-
peratures without affecting the target (3).
Conclusions
The authors did not found scientific evidence regarding 
the relation between a facial neuropathic pain and IPL 
treatment. In order to prevent accidents and unnecessary 
risks, a proper training of specialist staff regarding se-
curity and protection is required. This is mandatory for 
the specialist that applies treatments with different light 
sources to know the necessary prevention measures to 
avoid complications.
Detailed explanations about the possible side effects, 
proper selection of patients, cooling the treated area, 
and avoiding sun exposure between treatments may also 
contribute to a higher patient satisfaction rate and fewer 
complications. 
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